Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

Life expectancy in patients with multiple myeloma is increasing because of the availability of an increasing number of novel agents with various mechanisms of action against the disease. However, the disease remains incurable in most patients because of the emergence of resistant clones, leading to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mayo Clin Proc
Main Authors: Dingli, David, Ailawadhi, Sikander, Bergsagel, P. Leif, Buadi, Francis K., Dispenzieri, Angela, Fonseca, Rafael, Gertz, Morie A., Gonsalves, Wilson I., Hayman, Susan R., Kapoor, Prashant, Kourelis, Taxiarchis, Kumar, Shaji K., Kyle, Robert A., Lacy, Martha Q., Leung, Nelson, Lin, Yi, Lust, John A., Mikhael, Joseph R., Reeder, Craig B., Roy, Vivek, Russell, Stephen J., Sher, Taimur, Stewart, A. Keith, Warsame, Rahma, Zeldenrust, Stephen R., Rajkumar, S. Vincent, Chanan Khan, Asher A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5554888/
https://ncbi.nlm.nih.gov/pubmed/28291589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2017.01.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados